title: Assessment of soluble cell adhesion molecules and soluble CD40 ligand levels in ankylosing spondylitis.
authors.forename: Ismail
authors.initials: I
authors.lastname: Sari
authors.forename: Ahmet
authors.initials: A
authors.lastname: Alacacioglu
authors.forename: Levent
authors.initials: L
authors.lastname: Kebapcilar
authors.forename: Ali
authors.initials: A
authors.lastname: Taylan
authors.forename: Oktay
authors.initials: O
authors.lastname: Bilgir
authors.forename: Yasar
authors.initials: Y
authors.lastname: Yildiz
authors.forename: Arif
authors.initials: A
authors.lastname: Yuksel
authors.forename: Didem L
authors.initials: DL
authors.lastname: Kozaci
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D023201:CD40 Ligand / Q000097:blood*; D015815:Cell Adhesion Molecules / Q000097:blood*; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D013167:Spondylitis, Ankylosing / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D012460:Sulfasalazine / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015415:Biomarkers; D015815:Cell Adhesion Molecules; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D023201:CD40 Ligand; D012460:Sulfasalazine